We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$128M
AUM Growth
+$13.5M
Cap. Flow
-$1.11M
Cap. Flow %
-0.87%
Top 10 Hldgs %
26.71%
Holding
1,141
New
64
Increased
222
Reduced
212
Closed
55

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$189K
2
EQIX icon
Equinix
EQIX
+$93.7K
3
ALGN icon
Align Technology
ALGN
+$77.8K
4
MU icon
Micron Technology
MU
+$65.9K
5
AVGO icon
Broadcom
AVGO
+$63.2K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$949K
2
DLR.PRH.CL
Digital Realty Trust, Inc.
DLR.PRH.CL
+$296K
3
JNJ icon
Johnson & Johnson
JNJ
+$274K
4
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$144K
5
TSM icon
TSMC
TSM
+$95.4K

Sector Composition

Rank Sector Weight
1 Technology 28.37%
2 Healthcare 12.61%
3 Financials 10.22%
4 Consumer Staples 7.19%
5 Consumer Discretionary 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAP icon
526
Molson Coors Class B
TAP
$7.68B
$6K ﹤0.01%
101
+28
+38% +$1.73K
TER icon
527
Teradyne
TER
$54.8B
$6K ﹤0.01%
145
– –
TNDM icon
528
Tandem Diabetes Care
TNDM
$1.17B
$6K ﹤0.01%
100
– –
TRI icon
529
Thomson Reuters
TRI
$39.4B
$6K ﹤0.01%
96
-5
-5% -$279
TSLA icon
530
Tesla
TSLA
$1.24T
$6K ﹤0.01%
300
– –
UNP icon
531
Union Pacific
UNP
$183B
$6K ﹤0.01%
36
+15
+71% +$2.41K
WST icon
532
West Pharmaceutical
WST
$23.1B
$6K ﹤0.01%
50
+1
+2% +$104
WU icon
533
Western Union
WU
$2.57B
$6K ﹤0.01%
348
-7
-2% -$126
HZNP
534
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6K ﹤0.01%
211
– –
HIT
535
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
$6K ﹤0.01%
90
-1
-1% -$67
IFX
536
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
$6K ﹤0.01%
302
– –
CEO
537
DELISTED
CNOOC Limited
CEO
$6K ﹤0.01%
30
– –
AZPN
538
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$6K ﹤0.01%
62
– –
AAP icon
539
Advance Auto Parts
AAP
$3.37B
$5K ﹤0.01%
29
– –
AMED
540
DELISTED
Amedisys
AMED
$5K ﹤0.01%
37
– –
AVY icon
541
Avery Dennison
AVY
$12.3B
$5K ﹤0.01%
44
-15
-25% -$1.55K
BIO icon
542
Bio-Rad Laboratories Class A
BIO
$8.42B
$5K ﹤0.01%
15
– –
BJRI icon
543
BJ's Restaurants
BJRI
$1.41B
$5K ﹤0.01%
112
– –
BR icon
544
Broadridge
BR
$17.2B
$5K ﹤0.01%
47
– –
BSBR icon
545
Santander
BSBR
$39.7B
$5K ﹤0.01%
509
-31
-6% -$371
CGNX icon
546
Cognex
CGNX
$10.3B
$5K ﹤0.01%
95
– –
CRI icon
547
Carter's
CRI
$1.43B
$5K ﹤0.01%
50
– –
DELL icon
548
Dell
DELL
$283B
$5K ﹤0.01%
160
+71
+80% +$1.87K
DGRS icon
549
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
$401M
$5K ﹤0.01%
132
– –
EAT icon
550
Brinker International
EAT
$8.02B
$5K ﹤0.01%
112
+56
+100% +$2.52K
20 21
22
23 24

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Front Row Advisors held 1,141 positions worth $128M, up 12% from $115M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Front Row Advisors's Q1 2019 filing shows 64 new, 222 increased, 212 reduced and 55 closed positions. Its largest new stake was Vanguard Value ETF: 539 shares worth $58K. The largest sale was Biogen, an estimated $949K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Front Row Advisors's largest Q1 2019 buy was Vanguard Value ETF: 539 shares worth $58K.
  • Front Row Advisors added most to NVIDIA in Q1 2019, an estimated $189K increase.
  • Front Row Advisors's biggest Q1 2019 reduction was Biogen, cutting an estimated $949K.
  • Front Row Advisors fully exited Digital Realty Trust, Inc. in Q1 2019, selling an estimated $296K.
  • Front Row Advisors's ten largest holdings make up 27% of its $128M portfolio in Q1 2019.
  • Front Row Advisors opened 64 new positions and closed 55 in Q1 2019.
  • Front Row Advisors's portfolio value rose 12% quarter-over-quarter to $128M.

Based on Front Row Advisors's 13F filing for Q1 2019, filed 16 May 2019.